Cristin-person-ID: 49708
Person

Lars Bø

  • Stilling:
    Professor
    ved Klinisk institutt 1 ved Universitetet i Bergen
  • Stilling:
    Overlege / forsker
    ved Nevroklinikken ved Helse Bergen HF - Haukeland universitetssykehus

Resultater Resultater

A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.

Ahmad, Intakhar; Wergeland, Stig; Oveland, Eystein; Bø, Lars. 2021, PLOS ONE. HAUKELAND, UIBVitenskapelig artikkel

Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis.

Oveland, Eystein; Ahmad, Intakhar; Lereim, Ragnhild Reehorst; Kroksveen, Ann Cathrine; Barsnes, Harald; Guldbrandsen, Astrid; Myhr, Kjell-Morten; Bø, Lars; Berven, Frode Steingrimsen; Wergeland, Stig. 2021, Scientific Reports. HAUKELAND, UIBVitenskapelig artikkel

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis – A cohort study.

Torgauten, Hilde Marie; Myhr, Kjell-Morten; Wergeland, Stig; Bø, Lars; Aarseth, Jan Harald; Torkildsen, Øivind. 2021, Multiple Sclerosis Journal, Experimental, Translational and Clinical. HAUKELAND, UIBVitenskapelig artikkel

Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway.

Stokke, Silje Agnethe; Lehmann, Anne Kristine; Trovik, Linn; Kristoffersen, Einar Klæboe; Bø, Lars; Myhr, Kjell-Morten; Torkildsen, Øivind. 2019, Multiple Sclerosis. HAUKELAND, UIBVitenskapelig artikkel

Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.

Nystad, Agnes Elisabeth; Lereim, Ragnhild Reehorst; Wergeland, Stig; Oveland, Eystein; Myhr, Kjell-Morten; Bø, Lars; Torkildsen, Øivind. 2019, Journal of Neuroimmunology. HAUKELAND, UIBVitenskapelig artikkel
1 - 5 av 66 | Neste | Siste »